CervoMed Valuation
| CRVO Stock | 8.69 0.37 4.08% |
At this time, the firm appears to be overvalued. CervoMed shows a prevailing Real Value of USD7.41 per share. The current price of the firm is USD8.69. Our model approximates the value of CervoMed from analyzing the firm fundamentals such as Operating Margin of (24.94) %, shares outstanding of 9.25 M, and Return On Equity of -0.71 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that CervoMed's price fluctuation is slightly risky at this time. Calculation of the real value of CervoMed is based on 3 months time horizon. Increasing CervoMed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since CervoMed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CervoMed Stock. However, CervoMed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.69 | Real 7.41 | Hype 8.69 |
The intrinsic value of CervoMed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence CervoMed's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of CervoMed helps investors to forecast how CervoMed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CervoMed more accurately as focusing exclusively on CervoMed's fundamentals will not take into account other important factors: CervoMed Total Value Analysis
CervoMed is currently anticipated to have valuation of 49.32 M with market capitalization of 83.83 M, debt of 3.88 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the CervoMed fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
49.32 M | 83.83 M | 3.88 M |
CervoMed Investor Information
About 32.0% of the company shares are held by company insiders. The book value of CervoMed was currently reported as 2.81. The company recorded a loss per share of 2.9. CervoMed last dividend was issued on the 14th of December 2018. The entity had 2:3 split on the 17th of August 2023. Based on the measurements of operating efficiency obtained from CervoMed's historical financial statements, CervoMed is not in a good financial situation at this time. It has a very high odds of going through financial crisis in January.CervoMed Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CervoMed has an asset utilization ratio of 22.6 percent. This suggests that the Company is making USD0.23 for each dollar of assets. An increasing asset utilization means that CervoMed is more efficient with each dollar of assets it utilizes for everyday operations.CervoMed Ownership Allocation
The market capitalization of CervoMed is USD83.83 Million. CervoMed retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.CervoMed Profitability Analysis
The company reported the previous year's revenue of 9.74 M. Net Loss for the year was (16.29 M) with loss before overhead, payroll, taxes, and interest of (16.91 M).About CervoMed Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of CervoMed. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of CervoMed based exclusively on its fundamental and basic technical indicators. By analyzing CervoMed's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of CervoMed's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of CervoMed. We calculate exposure to CervoMed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CervoMed's related companies.CervoMed Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 8.1 M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CervoMed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in CervoMed Stock, please use our How to Invest in CervoMed guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CervoMed. If investors know CervoMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CervoMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of CervoMed is measured differently than its book value, which is the value of CervoMed that is recorded on the company's balance sheet. Investors also form their own opinion of CervoMed's value that differs from its market value or its book value, called intrinsic value, which is CervoMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CervoMed's market value can be influenced by many factors that don't directly affect CervoMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CervoMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if CervoMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CervoMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.